advertisement
Bikbov MM 25
Showing records 1 to 25 |
Display all abstracts from Bikbov MM106771 Myopia: Histology, clinical features, and potential implications for the etiology of axial elongationJonas JB
Progress in Retinal and Eye Research 2022; 0: 101156
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesBourne RRA
The Lancet. Global health 2022; 10: e1754-e1763
105227 Ankle-brachial index and ocular diseases in a Russian populationBikbov MM
Eye 2022; 36: 2294-2303
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesCicinelli MV
The Lancet. Global health 2022; 10: e1754-e1763
106771 Myopia: Histology, clinical features, and potential implications for the etiology of axial elongationJonas RA
Progress in Retinal and Eye Research 2022; 0: 101156
105227 Ankle-brachial index and ocular diseases in a Russian populationGilmanshin TR; Zainullin RM
Eye 2022; 36: 2294-2303
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesSedighi T
The Lancet. Global health 2022; 10: e1754-e1763
106771 Myopia: Histology, clinical features, and potential implications for the etiology of axial elongationBikbov MM
Progress in Retinal and Eye Research 2022; 0: 101156
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesTapply IH
The Lancet. Global health 2022; 10: e1754-e1763
106771 Myopia: Histology, clinical features, and potential implications for the etiology of axial elongationWang YX
Progress in Retinal and Eye Research 2022; 0: 101156
105227 Ankle-brachial index and ocular diseases in a Russian populationRakhimova EM; Rusakova IA
Eye 2022; 36: 2294-2303
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesMcCormick I
The Lancet. Global health 2022; 10: e1754-e1763
106771 Myopia: Histology, clinical features, and potential implications for the etiology of axial elongationPanda-Jonas S
Progress in Retinal and Eye Research 2022; 0: 101156
105227 Ankle-brachial index and ocular diseases in a Russian populationFakhretdinova AA
Eye 2022; 36: 2294-2303
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesJonas JB; Congdon NG
The Lancet. Global health 2022; 10: e1754-e1763
105227 Ankle-brachial index and ocular diseases in a Russian populationTuliakova AM; Kazakbaeva GM
Eye 2022; 36: 2294-2303
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesRamke J; Naidoo KS
The Lancet. Global health 2022; 10: e1754-e1763
105227 Ankle-brachial index and ocular diseases in a Russian populationPanda-Jonas S; Safiullina KR
Eye 2022; 36: 2294-2303
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesFricke TR; Burton MJ
The Lancet. Global health 2022; 10: e1754-e1763
105227 Ankle-brachial index and ocular diseases in a Russian populationBolshakova NI; Gizzatov AV
Eye 2022; 36: 2294-2303
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesMüller A; Bikbov MM
The Lancet. Global health 2022; 10: e1754-e1763
105227 Ankle-brachial index and ocular diseases in a Russian populationPonomarev IP; Nikitin NA
Eye 2022; 36: 2294-2303
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesFurtado JM; Kyari F
The Lancet. Global health 2022; 10: e1754-e1763
105227 Ankle-brachial index and ocular diseases in a Russian populationBaimukhametov NE; Jonas JB
Eye 2022; 36: 2294-2303
106058 Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countriesHe M; Wang YX; Vijaya L; Nangia V; Brian G; Emamian MH; Fotouhi A; Hashemi H; Khandekar RB; Marmamula S; Salomão S; George R; Kazakbaeva G; Braithwaite T; Casson RJ; Iwase A; Gupta N; Abdianwall MH; Varma R; Wong TY; Wang N; Taylor HR; Flaxman SR; Keel S; Resnikoff S;
The Lancet. Global health 2022; 10: e1754-e1763